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controls increased this rate to 0.61 μg/h, but Hyal-Joint® treated rats kept
the value of normal rats (0.43 μg/h new HA).
Conclusions: Our results suggest that the use of Hyal-Joint® for the
management of developing type II collagen arthritis in rats is safe and
effective, having beneﬁcial effects on the histopathology parameters in
ankles and knees. Analysis of synovial ﬂuid lavages indicates Hyal-Joint®
reduces absolute synthesis rate of HA into synovial ﬂuid of arthritic animals
to normal levels.
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Purpose: To evaluate the potential anti-arthritic activity of a formulation
that includes mannosamine hydrochloride (Mann) and chondroitin sul-
phate (CS) in an in vitro chondrocyte model and in an animal model of
osteoarthritis (OA) induced by meniscectomy.
Mann is an epimer of the natural Glucosamine Hydrochloride (Glu) and a
constituent of bacterial cell walls and is involved in a range of metabolic
processes. It is used as a probiotic in dietary supplements and functional
foods (Lactobacillus plantarum, Bacillus subtilis and Bacillus licheniformis).
Methods: The chondroprotective activity of a formulation based on Mann
+ CS (60 mg/kg/day + 95 mg/kg/day) was tested using a guinea pig model
of OA induced by partial medial meniscectomy. The following treatment
groups were established: blank control group, operated control group, CS
group (95 mg/kg/day), Mann groups (60 and 120 mg/kg/day) and CS +
Mann (95 +60 mg/kg/day). The administration of the corresponding oral
treatments (gastric gavage) was started the day after the surgery. The blank
control and operated control group only received water for injection. The
treatments were administered once a day for 70 days. After this period,
the animals were sacriﬁced by anaesthetic overdose. The femorotibial
joint of the right rear leg was removed. Histology was performed by a
pathologist, in a blind manner, after staining with Hematoxilin-Eosin and
Saffranin-O-Fast Green (or Toluidin Blue). The severity of the OA was
evaluated by the modiﬁed histological/histochemical scale of Mankin et al
(1971). The statistical evaluation between the different groups was carried
out by means of the Mann-Whitney U test.
An in vitro study was performed using bovine chondrocytes cultured in
alginate beads (n=4) in order to compare the activity of a mixture of
Glu+CS versus Mann+CS on extracellular matrix degradation and apoptosis.
Effects on apoptosis were determined by measuring Caspase-3/Caspase-7
activity after a three days of exposure to TNF-α. Effects on degradation
were determined by measuring Metalloprotease activity (MMP activity)
after stimulation with IL-1β for 48 hours followed by APMA activation.
MMP activity was quantiﬁed using a ﬂuorogenic MMP substrate.
Results: In the experimental conditions of the in vivo study, we found that
there were no statistically signiﬁcant differences between the operated
group and the group treated with Mann. The group treated with CS showed
improvement when compared to the operated group, but without statisti-
cal signiﬁcance. In the group treated with the CS and Mann combination,
statistically signiﬁcant improvements were achieved when compared to
the operated group (p<0.05).
The in vitro assays showed that Mann + CS leads to a statistically signiﬁcant
(p<0.05) reduction of apoptosis at medium and high concentrations and
also a reduction in the MMP activity at low and high concentrations. These
effects were not observed in the comparative mixture Glu + CS.
Conclusions: The eﬃcacy study in guinea pig indicates that there is a syner-
gic effect between Mann and CS when they are administered together. The
in vitro studies suggest that the combination Mannosamine Hydrochloride
and Chondroitin sulphate may have a higher chondroprotective activity
than the already marketed formulation of Glucosamine Hydrochloride and
Chondroitin Sulphate.
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A COMBINATION OF A SPECIFIC COLLAGEN HYDROLYSATE WITH A
REFINED ROSE HIP EXTRACT HAS A POSITIVE EFFECT ON THE EXTRA
CELLULAR MATRIX MAINTENANCE OF CARTILAGE CELLS
M. Schunck, S. Oesser
Collagen Res. Inst., Kiel, Germany
Purpose: Experimental studies have demonstrated a stimulatory impact of
collagen hydrolysate on the biosynthesis of cartilage tissue. In addition,
rose hip extracts are described for an anti-inﬂammatory potential.
Aim of the present study was to investigate the inﬂuence of a combination
of both collagen hydrolysate and a rose hip extract in order to determine
the stimulatory and anti-inﬂammatory eﬃcacy on the matrix synthesis of
articular cartilage cells.
Methods: For the investigations a combination of a speciﬁc collagen hy-
drolysate (Fortigel™, GELITA AG, Germany) and a processed aqueous rose
hip extract (nutriﬁn™ motion, Finzelberg, Germany) was used.
Mature articular chondrocytes were isolated from cartilage tissue and the
cells were cultivated in cell culture medium at 37°C under oxygen reduced
conditions (5% O2).
Three days after cell preparation chondrocytes were treated with a combi-
nation of 0.5 mg/ml FORTIGEL™ and 0.05 mg/ml nutriﬁn™ motion.
At the end of the observation period the collagen and proteoglycan biosyn-
thesis of the chondrocytes was quantiﬁed and the results were compared
to the corresponding data of the untreated control cells. To conﬁrm the
stimulatory effect on matrix macromolecule synthesis mRNA expression of
aggrecan and type II collagen was determined.
Moreover, the inhibitory effect of the FORTIGEL™/nutriﬁn™ motion com-
bination on inﬂammatory cytokines (TNFα, IL-6) and matrix degradation
(MMP-1, MMP-13) were tested.
Results: The supplementation of a FORTIGEL™/nutriﬁn™ motion combi-
nation led to a statistically signiﬁcant (p<0.05) stimulation of the extra
cellular matrix synthesis of articular chondrocytes. Type II collagen and
aggrecan biosynthesis was increased by more than 45% in comparison to
the untreated control cells.
Moreover, an anti-inﬂammatory effect as well as an inhibitory impact on
MMP-1 and MMP-13 expression could be observed after FORTIGEL™ and
nutriﬁn™ motion administration compared to the untreated chondrocytes.
Conclusions: The results indicate the eﬃcacy of FORTIGEL™ and nutriﬁn™
motion to stimulate extra cellular matrix biosynthesis and to decrease
inﬂammatory and catabolic processes. These data suggested that especially
a combination of both substances seems to be of particular therapeutic
relevance in the treatment and prevention of osteoarthritis.
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EVALUATION OF THE ADHESION TO THE EULAR AND OARSI
RECOMMENDATIONS FOR THE TREATMENT OF KNEE AND HIP
OSTEOARTHRITIS IN CURRENT PRACTICE
D. Van Linthoudt
Hôpital neuchâtelois, La Chaux-de-Fonds, Switzerland
Purpose: The aim of this study was to evaluate, in real life, the acceptance
of the EULAR and OARSI recommendations for the treatment of knee and
hip osteoarthritis (OA) in the two districts of the Neuchâtel Mountains.
Methods: In March 2008, a questionnaire was sent to all the general
practitioners (GP = 23), internists (IM = 22), orthopedic surgeons (ORTHO
= 8) and rheumatologists (RHEUMATO = 3) of the districts of Le Locle
